Last updated on December 2019

A Study of the Efficacy and Safety of Upadacitnib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies

Find a site near you

Start Over

HP Clinical Research /ID# 164933

Bountiful, UT United States
  Connect »